Ketamine and esketamine (Spravato) infusion clinics operate under a level of regulatory documentation overhead that distinguishes them sharply from standard outpatient psychiatric practices. Esketamine (Spravato) carries an FDA Risk Evaluation and Mitigation Strategy (REMS) requirement that imposes specific obligations on prescribers, pharmacies, and certified healthcare settings. Ketamine infusion, while not subject to REMS, requires careful pre-screening and monitoring protocols to manage safety risks. For clinics running high volumes of treatment-resistant depression patients, managing this regulatory and clinical coordination load without dedicated administrative support is unsustainable.
Virtual assistants trained in ketamine and esketamine clinic protocols are stepping in to manage the documentation, scheduling, and referral tracking functions that protect both program compliance and patient safety.
Spravato REMS Documentation Requirements
The FDA's REMS program for esketamine (Spravato) requires that prescribers enroll in the Spravato REMS program, that each treatment occur at a certified healthcare setting (REMS-enrolled facility), and that patients be enrolled and monitored according to REMS protocols. Key documentation obligations include: patient enrollment in the REMS, monitoring checklists for each treatment session (blood pressure readings at defined intervals), and attestation by the healthcare provider that monitoring requirements were met.
According to Janssen Pharmaceuticals, the Spravato manufacturer, REMS non-compliance is one of the most common barriers to program sustainability at smaller clinic settings—because the documentation burden is underestimated at program launch. A virtual assistant can maintain the REMS enrollment tracking database, prepare session-specific monitoring checklists, and ensure post-session attestation documentation is completed and filed—keeping the program audit-ready at all times.
Spravato Observation Period Scheduling
Esketamine cannot be dispensed for home use. Each treatment session requires the patient to remain in the certified healthcare setting for at least two hours post-administration for observation of dissociation, sedation, and cardiovascular effects. This makes session scheduling fundamentally different from standard outpatient appointments: block scheduling must account for the observation period, treatment rooms must be reserved for the full session-plus-observation window, and discharge criteria must be documented before the patient leaves.
A virtual assistant can manage the Spravato session scheduling matrix: booking treatment appointments with appropriate room block times, sending pre-session instructions to patients (including fasting requirements and transportation arrangements—patients cannot drive post-treatment), and coordinating with clinical staff on observation documentation checklists.
Ketamine Infusion Pre-Screening Coordination
IV ketamine infusion for depression and psychiatric indications is not FDA-approved for these uses and is therefore self-pay in most cases, but pre-screening is critical both for patient safety and for setting appropriate clinical expectations. Standard pre-screening typically involves psychiatric evaluation confirming appropriate diagnosis and failed antidepressant trials, medical clearance reviewing cardiovascular and anesthetic risk, and informed consent documentation.
A virtual assistant can coordinate the pre-screening workflow: scheduling the psychiatric evaluation and medical clearance, collecting and organizing pre-screening documentation, obtaining signed informed consent forms, and confirming that all pre-infusion requirements are met before scheduling the infusion series. This reduces the risk of late cancellations and ensures clinical readiness at first infusion.
Follow-Up Psychiatrist Referral Tracking
Ketamine and esketamine infusion is rarely a standalone intervention—it is most effective when integrated with ongoing psychiatric medication management and psychotherapy. Many infusion clinics operate without embedded psychiatrists, requiring a robust referral relationship network and active follow-up to confirm that patients are connected to ongoing psychiatric care after an infusion series.
A 2023 analysis in the Journal of Affective Disorders found that patients who received structured psychiatric follow-up after ketamine infusion had significantly higher rates of sustained remission at 90 days compared to those without documented follow-up care. A virtual assistant can manage the referral tracking workflow: documenting referrals at discharge, following up with patients at defined intervals to confirm appointment completion, and flagging cases where follow-up has not been confirmed for clinical team outreach.
The Compliance and Revenue Case
A single REMS compliance failure—whether a missed monitoring checklist or an unenrolled prescriber—can result in program suspension that eliminates all revenue until the deficiency is corrected. For a clinic generating $50,000 to $150,000 per month in Spravato and ketamine infusion revenue, administrative failures carry existential financial stakes.
Virtual assistants provide the systematic, protocol-driven documentation management that REMS compliance demands. Infusion clinics building scalable administrative infrastructure can connect with trained VAs at Stealth Agents.
The clinical outcomes of ketamine and esketamine for treatment-resistant depression are among the most promising in psychiatry. Protecting those outcomes requires administrative systems as rigorous as the treatment protocols themselves.
Sources
- FDA. Spravato (esketamine) REMS Program Overview and Requirements. fda.gov
- Janssen Pharmaceuticals. Spravato REMS Healthcare Provider Enrollment and Documentation Guide. spravatorems.com
- Wilkinson ST, et al. Ketamine Infusion Follow-Up and Sustained Remission in Treatment-Resistant Depression. Journal of Affective Disorders, 2023. sciencedirect.com
- American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3). Clinical and Administrative Standards for Ketamine Infusion Programs. askp3.org